Literature DB >> 26775377

Assessment of bloodstream infections and risk factors in an intensive care unit.

Aynur Süner, Ilkay Karaoğlan, Ayşe Ozlem Mete, Mustafa Namiduru, Vuslat Boşnak, Ibrahim Baydar.   

Abstract

BACKGROUND/AIM: Nosocomial bloodstream infection (BSI) increases mortality rates, duration of stay in hospital, and treatment costs. This study was conducted to determine the rate and the risk factors of BSIs among intensive care unit patients.
MATERIALS AND METHODS: Sixty-four patients with BSIs (patient group) and 79 patients without a nosocomial infection (control group) were enrolled in the study. Centers for Disease Control and Prevention criteria were used for diagnosing BSIs. Potential risk factors were evaluated by multivariate logistic regression model.
RESULTS: The BSI development rate was 15.7% (64/407), with an incidence rate of 18.2/1000 patient days. Distribution of pathogens among BSI patients were as follows: gram-positive cocci, 42.18% (27/64); gram-negative cocci, 34.3% (22/64); and Candida spp., 23.4% (15/64). Risk factors were determined as intubation, arterial catheter, tracheostomy, duration of intubation, duration of catheter use, duration of nasogastric catheter, underlying diseases of chronic renal failure and diabetes mellitus, implemented treatments of sedation and enteral nutrition, and APACHE II score.
CONCLUSION: : BSIs are the leading cause of mortality and morbidity in intensive care unit patients. Determination of the local risk factors is important and necessary for decreasing the rate of BSIs and the mortality rates.

Entities:  

Mesh:

Year:  2015        PMID: 26775377     DOI: 10.3906/sag-1303-41

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  4 in total

1.  Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit.

Authors:  Tuna Demirdal; Pinar Sen; Salih Atakan Nemli
Journal:  Indian J Crit Care Med       Date:  2018-02

2.  Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes.

Authors:  Bo Tu; Jingfeng Bi; Dan Wu; Peng Zhao; Lei Shi; Yangxin Xie; Xin Zhang; Zhe Xu; Suxia Liu; Xinhua Wang; Xiaoxi Li; Fusheng Wang; Enqiang Qin
Journal:  Oncotarget       Date:  2017-12-13

3.  Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.

Authors:  Simon Brinkwirth; Olaniyi Ayobami; Tim Eckmanns; Robby Markwart
Journal:  Euro Surveill       Date:  2021-11

Review 4.  Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.

Authors:  Mansi Agarwal; Stephanie Shiau; Elaine L Larson
Journal:  J Infect Public Health       Date:  2017-10-20       Impact factor: 3.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.